Though the mechanism by which PPAR-β/δ acts remains largely unknown and not yet fully characterized, we wanted to demonstrate a possible therapeutic involvement of the PPAR-β/δ isoform in an acute inflammatory disease such as zymosan-induced multiple organ failure. This evidence concerns the gene PPARD and Multiple Organ Failure.